Perspective Therapeutics, Inc.
Dashboard
Perspective Therapeutics, Inc.
CATXNYSE AmericanFor informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.
Universal block
Live market data + trailing fundamentals.
Market cap$332M
Price$2.9152w $2.05 – $5.65
Conviction3/ 5
Revenue (TTM)$618,000
Revenue growth YoY-58.0%
P/E (trailing)—
Gross margin-489.8%
Operating margin-19419.6%
Net margin-17982.7%
52w price change+21.8%
Next earningsAug 12, 2026
Recent events
Material filings, federal awards, and regulatory activity. Impact is scored against market cap.
- Jul 1OtherSEC
8-K filing with items 8.01 (other events) and 9.01.
- Jun 1OtherSEC
8-K filing (items 8.01, 9.01) on 2026-06-01 disclosing other events.
- May 27OtherSEC
8-K item 5.07 filing on matters submitted to security holder vote.
- May 22OtherSEC
Filed 8-K on 2026-05-22 covering items 8.01 (other events) and 9.01.
- May 11Financial resultsSEC
8-K filing (items 2.02, 8.01, 9.01) reporting financial results.
Not financial advice — research and opinion only. Disclosures